- Home
- HLN vs TAK Comparison
HLN vs TAK Comparison
Compare HLN & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLN
- TAK
- Stock Information
- Founded
- HLN 2022
- TAK 1781
- Country
- HLN United Kingdom
- TAK Japan
- Employees
- HLN N/A
- TAK N/A
- Industry
- HLN Package Goods/Cosmetics
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- HLN Consumer Discretionary
- TAK Health Care
- Exchange
- HLN Nasdaq
- TAK Nasdaq
- Market Cap
- HLN 43.9B
- TAK 42.5B
- IPO Year
- HLN N/A
- TAK N/A
- Fundamental
- Price
- HLN $9.71
- TAK $13.12
- Analyst Decision
- HLN Strong Buy
- TAK
- Analyst Count
- HLN 2
- TAK 0
- Target Price
- HLN $10.48
- TAK N/A
- AVG Volume (30 Days)
- HLN 7.2M
- TAK 1.8M
- Earning Date
- HLN 08-01-2024
- TAK 01-30-2025
- Dividend Yield
- HLN 1.60%
- TAK 4.76%
- EPS Growth
- HLN N/A
- TAK 49.73
- EPS
- HLN 0.18
- TAK 1.27
- Revenue
- HLN $15,065,004,686.00
- TAK $31,732,209,416.00
- Revenue This Year
- HLN $2.92
- TAK $4.41
- Revenue Next Year
- HLN $2.80
- TAK $1.09
- P/E Ratio
- HLN $27.25
- TAK $20.89
- Revenue Growth
- HLN N/A
- TAK 9.43
- 52 Week Low
- HLN $7.89
- TAK $12.58
- 52 Week High
- HLN $10.80
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- HLN 50.02
- TAK 35.28
- Support Level
- HLN $9.70
- TAK $13.46
- Resistance Level
- HLN $9.95
- TAK $13.42
- Average True Range (ATR)
- HLN 0.11
- TAK 0.15
- MACD
- HLN 0.02
- TAK -0.03
- Stochastic Oscillator
- HLN 40.96
- TAK 0.54
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.